Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Microbot Medical (MBOT) Common Equity (2016)

Microbot Medical's Common Equity history spans 7 years, with the latest figure at -$2.1 million for Q3 2016.

  • For the quarter ending Q3 2016, Common Equity fell 129.85% year-over-year to -$2.1 million, compared with a TTM value of -$2.1 million through Sep 2016, down 129.85%, and an annual FY2015 reading of -$64000.0, changed N/A over the prior year.
  • Common Equity for Q3 2016 was -$2.1 million at Microbot Medical, up from -$4.9 million in the prior quarter.
  • The five-year high for Common Equity was $15.7 million in Q3 2014, with the low at -$6.9 million in Q1 2016.
  • Average Common Equity over 5 years is $5.0 million, with a median of $5.4 million recorded in 2012.
  • Year-over-year, Common Equity soared 700.04% in 2015 and then tumbled 192.08% in 2016.
  • Tracing MBOT's Common Equity over 5 years: stood at $14.0 million in 2012, then rose by 6.93% to $15.0 million in 2013, then plummeted by 94.27% to $857000.0 in 2014, then plummeted by 107.47% to -$64000.0 in 2015, then plummeted by 3215.21% to -$2.1 million in 2016.
  • Per Business Quant, the three most recent readings for MBOT's Common Equity are -$2.1 million (Q3 2016), -$4.9 million (Q2 2016), and -$6.9 million (Q1 2016).